Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome(®) and AmBisome(®) in murine cutaneous leishmaniasis

Fungisome(®) (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effective therapeutic for the parasitic infection visceral leishmaniasis. Its potential in the treatment of cutaneous leishmaniasis (CL), a disfiguring form of the disease affecting the skin, is currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijnant, Gert-Jan, Van Bocxlaer, Katrien, Yardley, Vanessa, Harris, Andy, Alavijeh, Mo, Silva-Pedrosa, Rita, Antunes, Sandra, Mauricio, Isabel, Murdan, Sudaxshina, Croft, Simon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039306/
https://www.ncbi.nlm.nih.gov/pubmed/29673889
http://dx.doi.org/10.1016/j.ijpddr.2018.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039306/
https://www.ncbi.nlm.nih.gov/pubmed/29673889
http://dx.doi.org/10.1016/j.ijpddr.2018.04.001

Ejemplares similares